Stronger synapses, more efficient neurons: an evidence map of learning-timed interventions and a gap check of an NMDA co-agonist plus PDE4-inhibitor combination
Background: Learning strengthens synapses through a chain of molecular steps. Two steps have drug entry points with human data: co-activation of the NMDA receptor during encoding, and cAMP signalling during consolidation. Methods: The author searched PubMed, Google Scholar, Espacenet and ClinicalTrials.gov in October 2026, checked each citation against PubMed or the full text, graded the evidence for healthy adults, and re-analysed the posted results of one unpublished trial (NCT02051335). Results: Retrieval practice (g = 0.50, 95% CI [0.42, 0.58]) and spaced practice (d = 0.46, 95% CI [0.42, 0.50]) carry the strongest evidence. Low-dose roflumilast (100 µg) improved word recall in two crossover studies of 20 healthy adults each, both from one research group, with no effect on recall after 24 h. D-serine has two single-dose studies in healthy adults that report no standardized effect sizes. The searches found no study, trial or patent that combines an NMDA co-agonist with a PDE4 inhibitor to improve memory. In NCT02051335, one of ten primary comparisons survives a Holm correction (adjusted p = 0.04). Conclusions: D-serine plus roflumilast is an untested combination. The report proposes a human 2 × 2 crossover with single doses before learning, 45-minute delayed recall as the primary outcome and about 22 completers. This is a preprint and has not been peer reviewed. Nothing in it recommends taking any compound.
Authors
- Matias Vermeire (ORCID: https://orcid.org/0009-0007-7134-5531)
Institutions
- Maastricht University (NL)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.5281/zenodo.24397313
- Primary Topic
- Memory and Neural Mechanisms
- Type
- preprint